-threonine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9175044
APP PUB NO 20130171180A1
SERIAL NO

13823237

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, as well as to their process of preparation, their use in the peptide synthesis, said peptide and the use of said peptide.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TFCHEM27100 VAL DE REUIL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deliencourt-Godefroy, Geraldine Bois d'Ennebourg, FR 5 3
Fillon, Hyacinthe Saint Etienne du Rouvray, FR 3 1
Martin, Thibaut Mont Saint Aignan, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 3, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00